ProShare Advisors LLC Has $1.33 Million Position in Integer Holdings Co. (NYSE:ITGR)

ProShare Advisors LLC boosted its holdings in Integer Holdings Co. (NYSE:ITGR) by 44.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,051 shares of the medical equipment provider’s stock after buying an additional 3,091 shares during the quarter. ProShare Advisors LLC’s holdings in Integer were worth $1,332,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Integer by 3.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,678 shares of the medical equipment provider’s stock valued at $2,740,000 after acquiring an additional 685 shares during the period. Fred Alger Management LLC bought a new stake in shares of Integer in the fourth quarter worth $2,545,000. D. E. Shaw & Co. Inc. increased its holdings in Integer by 33.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 9,516 shares of the medical equipment provider’s stock valued at $1,261,000 after purchasing an additional 2,384 shares during the period. Deutsche Bank AG raised its position in Integer by 49.8% during the 4th quarter. Deutsche Bank AG now owns 29,381 shares of the medical equipment provider’s stock worth $3,894,000 after purchasing an additional 9,770 shares during the last quarter. Finally, Driehaus Capital Management LLC raised its position in Integer by 5.5% during the 4th quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider’s stock worth $59,828,000 after purchasing an additional 23,706 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Trading Down 2.2%

NYSE ITGR opened at $118.87 on Thursday. The stock has a market capitalization of $4.15 billion, a P/E ratio of 35.38, a P/E/G ratio of 1.72 and a beta of 1.03. The business has a 50 day simple moving average of $118.43 and a 200 day simple moving average of $129.34. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $437.39 million for the quarter, compared to analysts’ expectations of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.14 EPS. Research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer now directly owns 47,000 shares of the company’s stock, valued at $5,788,990. The trade was a 87.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 2.16% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ITGR has been the topic of a number of analyst reports. KeyCorp reduced their price target on Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. StockNews.com raised Integer from a “sell” rating to a “hold” rating in a research note on Monday. Truist Financial set a $150.00 target price on shares of Integer and gave the company a “buy” rating in a research report on Friday, April 25th. Benchmark lowered their price target on shares of Integer from $150.00 to $140.00 and set a “buy” rating for the company in a report on Friday, April 25th. Finally, Raymond James boosted their price target on shares of Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, April 25th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.